Ran Li
Kunming, 650101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
SIRT6 inhibits intermittent hypoxia-induced lung injury by stabilizing NRF2.
Journal: Tissue & cell
Published: September 02, 2025
Tempol suppresses ferroptosis and relieves chronic intermittent hypoxia-induced lung injury through the inhibition of TLR4 and activation of the Nrf2/GSH axis.
Journal: Tissue & cell
Published: August 02, 2025
Construction and Validation of a Nomogram Model for Predicting Pulmonary Hypertension in Patients with Obstructive Sleep Apnea.
Journal: Nature and science of sleep
Published: February 10, 2025
BPQDs@Lipo-YSA Nanoplatform Triggers Mitophagy via PRKN/AKT1 to Drive Immunogenic Cell Death in Lung Adenocarcinoma.
Journal: Journal of nanobiotechnology
Published: November 19, 2024
The diagnostic efficacy of metagenomic next-generation sequencing (mNGS) in pathogen identification of pediatric pneumonia using bronchoalveolar lavage fluid (BALF): A systematic review and meta-analysis.
Journal: Microbial pathogenesis
Published: June 25, 2024
An integrated bioinformatics analysis to identify the shared biomarkers in patients with obstructive sleep apnea syndrome and nonalcoholic fatty liver disease.
Journal: Frontiers in genetics
Published: January 18, 2024
Tempol attenuates chronic intermittent hypoxia-induced lung injury through the miR-145-5p/Nrf2 signaling pathway.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: October 26, 2023
4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) alleviates lung injury by inhibiting SIRT6-HIF-1α signaling pathway activation through the upregulation of miR-212-5p expression.
Journal: Molecular biology reports
Published: August 26, 2023
Association of oxygen saturation and mortality in patients with acute respiratory failure.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: June 25, 2023
Tempol alleviates acute lung injury by affecting glutathione synthesis through Nrf2 and inhibiting ferroptosis in lung epithelial cells.
Journal: Journal of biochemical and molecular toxicology
Published: April 17, 2023
Analysis of miRNA expression profile in lung tissues of an intermittent hypoxia rat model.
Journal: Respiratory physiology & neurobiology
Published: April 02, 2021
Tempol relieves lung injury in a rat model of chronic intermittent hypoxia via suppression of inflammation and oxidative stress.
Journal: Iranian journal of basic medical sciences
Published: January 11, 2019
Last Updated: 09/26/2026